Celine B E Busch - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Celine B E Busch

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Gastrointestinal Endoscopy|December 17, 2025

ResponseCeline B E Busch, Annieke C G van Baar

The American Journal of Gastroenterology|February 19, 2024

Role of the Intestine and Its Gut Microbiota in Metabolic Syndrome and ObesityCeline B E Busch, Jacques J G H M Bergman, Max Nieuwdorp, et al.

BMJ Nutrition, Prevention & Health|August 7, 2025

Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetesCeline B E Busch, Julia Rubingh, Annieke C G van Baar, et al.

Endoscopy|December 17, 2025

Barotrauma and delayed perforation upon endoscopic laser ablation of the duodenal mucosa for type 2 diabetes: a case reportKim van den Hoek, Celine B E Busch, Sabrine Q Kol, et al.

Gastrointestinal Endoscopy|May 1, 2024

Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human studyCeline B E Busch, Suzanne Meiring, Annieke C G van Baar, et al.

Endoscopy International Open|February 26, 2025

Optimizing duodenal tissue acquisition for mechanistic studies of duodenal ablation in type 2 diabetesCeline B E Busch, Kim van den Hoek, E Andra Neefjes-Borst, et al.

Igie : Innovation, Investigation and Insights|February 6, 2026

Durable insulin elimination after duodenal re-cellularization via electroporation therapy combined with glucagon-like peptide-1 receptor agonist in patients with type 2 diabetesCeline B E Busch, Kim van den Hoek, Annieke C G van Baar, et al.

Gastrointestinal Endoscopy|January 27, 2024

Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot studyCeline B E Busch, Suzanne Meiring, Annieke C G van Baar, et al.

Journal of Hepato-Biliary-Pancreatic Sciences|December 21, 2021

Performance of diagnostic tools for acute cholangitis in patients with suspected biliary obstructionChristina J Sperna Weiland, Celine B E Busch, Abha Bhalla, et al.

Pageof 1

Search research articles

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Gastrointestinal Endoscopy|December 17, 2025

ResponseCeline B E Busch, Annieke C G van Baar

The American Journal of Gastroenterology|February 19, 2024

Role of the Intestine and Its Gut Microbiota in Metabolic Syndrome and ObesityCeline B E Busch, Jacques J G H M Bergman, Max Nieuwdorp, et al.

BMJ Nutrition, Prevention & Health|August 7, 2025

Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetesCeline B E Busch, Julia Rubingh, Annieke C G van Baar, et al.

Endoscopy|December 17, 2025

Barotrauma and delayed perforation upon endoscopic laser ablation of the duodenal mucosa for type 2 diabetes: a case reportKim van den Hoek, Celine B E Busch, Sabrine Q Kol, et al.

Gastrointestinal Endoscopy|May 1, 2024

Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human studyCeline B E Busch, Suzanne Meiring, Annieke C G van Baar, et al.

Endoscopy International Open|February 26, 2025

Optimizing duodenal tissue acquisition for mechanistic studies of duodenal ablation in type 2 diabetesCeline B E Busch, Kim van den Hoek, E Andra Neefjes-Borst, et al.

Igie : Innovation, Investigation and Insights|February 6, 2026

Durable insulin elimination after duodenal re-cellularization via electroporation therapy combined with glucagon-like peptide-1 receptor agonist in patients with type 2 diabetesCeline B E Busch, Kim van den Hoek, Annieke C G van Baar, et al.

Gastrointestinal Endoscopy|January 27, 2024

Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot studyCeline B E Busch, Suzanne Meiring, Annieke C G van Baar, et al.

Journal of Hepato-Biliary-Pancreatic Sciences|December 21, 2021

Performance of diagnostic tools for acute cholangitis in patients with suspected biliary obstructionChristina J Sperna Weiland, Celine B E Busch, Abha Bhalla, et al.

Pageof 1